Skip to main content
NCBI home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1994 May;85(5):485–490. doi: 10.1111/j.1349-7006.1994.tb02384.x

Cumulative Risk of Hepatocellular Carcinoma in Hepatitis C Virus Carriers: Statistical Estimations from Cross‐sectional Data

Hideo Tanaka 1, Tomohiko Hiyama 1, Hideaki Tsukuma 1, Isaburo Fujimoto 1, Hajime Yamano 2, Yasuto Okubo 2, Akira Kitada 2
PMCID: PMC5919499  PMID: 8014106

Abstract

The probability of developing hepatocellular carcinoma (HCC) among hepatitis C virus (HCV) carriers during their life‐time is unknown. This paper addresses the estimation of the cumulative risk of HCC among HCV carriers using cross‐sectional data. Age‐specific prevalences of HCV carriers among the general population were estimated according to 5‐year age group, based on the data of 2nd‐generation anti‐HCV assay in blood donors resident in Osaka (33,226 males and 29,054 females). Seropositivity of anti‐HCV among 422 HCC cases, and the Osaka Cancer Registry data on HCC were used in the estimations of 5‐year age‐specific incidence rates of HCV‐linked HCC. Using these data, the cumulative risk, i.e., the probability of contracting HCC within the following 15 years in 50‐year‐old HCV carriers, was estimated as 28% for males and 6% for females.

Keywords: Hepatitis C virus, Hepatocellular carcinoma, Hepatitis C virus carrier, Cumulative risk, Epidemiology

Full Text

The Full Text of this article is available as a PDF (348.7 KB).

REFERENCES

  • 1. ) Yu , M. C. , Tong , M. J. , Coursaget , P. , Ross , R. K. , Govindarajan , S. and Henderson , B. E.Prevalence of hepatitis B and C viral markers in white and black patients with hepatocellular carcinoma in the United States . J. Natl. Cancer Inst. , 82 , 1038 – 1041 ( 1990. ). [DOI] [PubMed] [Google Scholar]
  • 2. ) Tanaka , K. , Hirohata , T. , Koga , S. , Sugimachi , K. , Kanematsu , K. , Ohryohji , K. , Nawata , H. , Ishibashi , H. , Maeda , Y. , Kiyokawa , H. , Tokunaga , K. and Irita , Y.Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population . Cancer Res. , 51 , 2842 – 2847 ( 1991. ). [PubMed] [Google Scholar]
  • 3. ) Yu , M.‐W. , You , S.‐L. , Chang , A.‐S. , Lu , S.‐N. , Liaw , Y.‐F. and Chen , C.‐J.Association between hepatitis C virus antibodies and hepatocellular carcinoma in Taiwan . Cancer Res. , 51 , 5621 – 5625 ( 1991. ). [PubMed] [Google Scholar]
  • 4. ) Kaklamani , E. , Trichopoulos , D. , Tzonou , A. , Zavitsanos , X. , Koumantaki , Y. , Hatzakis , A. , Hsieh , C. C. and Hatziyannis , S.Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma . J. Am. Med. Assoc. , 265 , 1974 – 1976 ( 1991. ). [PubMed] [Google Scholar]
  • 5. ) Chuang , W.‐L. , Chang , W.‐U. , Lu , S.‐N. , Su , W.‐P. , Lin , Z.‐Y. , Chen , S.‐C. , Hsieh , M.‐Y. , Wang , L.‐Y. , You , S.‐L. and Chen , C.‐J.The role of hepatitis B and C viruses in hepatocellular carcinoma in a hepatitis endemic area . Cancer , 69 , 2052 – 2054 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 6. ) Zavitsanos , X. , Hatzakis , A. , Kaklamani , E. , Tzonou , A. , Toupadaki , N. , Broeksma , C. , Chrispeels , J. , Troonen , H. , Hadzyannis , S. , Hsieh , C.‐C. , Alter , H. and Trichopoulos , D.Association between hepatitis C virus and hepatocellular carcinoma using assays based on structural and nonstructural hepatitis C virus peptides . Cancer Res. , 52 , 5364 – 5367 ( 1992. ). [PubMed] [Google Scholar]
  • 7. ) Simonetti , G. G. , Camma , C. , Fioretto , F. , Cottone , M. , Rapicetta , M. , Marino , M. , Firentino , G. , Craxi , A. , Ciccaglione , A. , Giuseppeti , R. , Stroffolini , T. and Pagliaro , L.Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis . Ann. Intern. Med. , 116 , 97 – 102 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 8. ) Tsukuma , H. , Hiyama , T. , Tanaka , S. , Nakao , M. , Yabuuchi , T. , Kitamura , T. , Nakanishi , K. , Fujimoto , I. , Inoue , A. , Yamazaki , H. and Kawashima , T.Risk factors for hepatocellular carcinoma among patients with chronic liver disease . N. Engl. J. Med. , 328 , 1797 – 1801 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 9. ) Kiyosawa , K. , Sodeyama , T. , Tanaka , E. , Gibo , Y. , Yoshizawa , K. , Nakano , Y. , Furuta , S. , Akahane , Y. , Nishioka , K. , Purcell , R. H. and Alter , H. J.Interrelationship of blood transfusion non‐A, non‐B, hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus . Hepatology , 12 , 671 – 675 ( 1990. ). [DOI] [PubMed] [Google Scholar]
  • 10. ) Tanaka , H. , Hiyama , T. , Okubo , Y. , Kitada , A. and Fujimoto , I.Primary liver cancer incidence rates related to hepatitis C virus infection: a correlational study in Osaka . Cancer Causes Control , 5 , 61 – 65 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 11. ) Parkin , D. M. , Muir , C. S. , Whelan , S. L. , Gao , Y.‐T. , Ferlay , J. and Powell , J. “ Cancer Incidence in Five Continents Volume VI ,” IARC Scientific Publications No. 120 ( 1992. ). International Agency for Research on Cancer; , Lyon . [Google Scholar]
  • 12. ) Hiyama , T. , Tsukuma , H. , Fujimoto , I. and Pyong , S.‐J.Comparison of liver cancer occurrence among Koreans in Korea and Koreans and Japanese in Osaka . Proc. Korea-Japan Liver Cancer Symp. , pp. 27 – 35 ( 1992. ). [Google Scholar]
  • 13. ) Iino , S. , Koike , K. , Yasuda , K. , Hino , K. , Tsumakami , S. , Suzuki , H. , Akahane , Y. , Kiyosawa , K. , Tanaka , E. , Yosizawa , H. , Nakanishi , T. , Tamura , T. , Sata , M. , Watoji , S. , Nishioka , K. and Watanabe , J.Second‐generation assay for antibody to hepatitis C virus by passive hemagglutination . Prog. Med. , 7 , 1911 – 1921 ( 1991. ) ( in Japanese ). [Google Scholar]
  • 14. ) Watanabe , J. , Matsumoto , C. , Fujimura , K. , Shimada , T. , Yoshizawa , H. , Okamoto , H. , Iizuka , H. , Tango , T. , Ikeda , H. , Endo , N. , Mazda , T. , Nojiri , T. , Aoyama , K. , Kanemitsu , K. , Yamano , H. , Mizui , M. , Yokoishi , F. , Tokunaga , K. and Nishioka , K.Predictive value of screening tests for persistent hepatitis C virus infection evidenced by viremia . Vox Sang. , 65 , 199 – 203 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 15. ) Fujimoto , I. , Hanai , A. , Oshima , A. , Hiyama , T. , Tsukuma , H. , Murakami , R. , Sobue , T. , Tanaka , H. and Ajiki , W.Trend in incidence and mortality rates for selected primary sites in Osaka . In “ Cancer Incidence and Mortality in Osaka 1963–89 ,” ed. Fujimoto I. , pp. 21 – 29 ( 1993. ). Osaka Foundation for Prevention of Cancer and Circulatory Diseases; , Osaka . [Google Scholar]
  • 16. ) “ Annual Report of Osaka Cancer Registry No. 50 ” ( 1991. ). Osaka Prefectural Health Department; , Osaka ( in Japanese ). [Google Scholar]
  • 17. ) Hayashi , N. , Takehara , T. , Hagiwara , H. , Fusamoto , H. and Kamata , T.Clinical importance of hepatitis C virus in Japanese hepatocellular carcinoma . Saishin Igaku , 47 , 1459 – 1465 ( 1992. ) ( in Japanese ). [Google Scholar]
  • 18. ) Day , N. E.Cumulative rate and cumulative risk . In “ Cancer Incidence in Five Continents, Volume IV ,” ed. Waterhouse J. , Muir C. , Shanmugaratnam K. and Powell J. , IARC Scientific Publications No. 42 , pp. 443 – 445 ( 1982. ). International Agency for Research on Cancer; , Lyon . [Google Scholar]
  • 19. ) Resnick , R. H. , Stone , K. and Antonioli , D.Primary hepatocellular carcinoma following non‐A, non‐B post‐transfusion hepatitis . Dig. Dis. Sci. , 28 , 908 – 911 ( 1983. ). [DOI] [PubMed] [Google Scholar]
  • 20. ) Kiyosawa , K. , Akahane , Y. , Nagata , A. and Furuta , S.Hepatocellular carcinoma after non‐A, non‐B post‐transfusion hepatitis . Am. J. Gastroenterol. , 79 , 777 – 781 ( 1984. ). [PubMed] [Google Scholar]
  • 21. ) Cohen , E. B. , Gang , D. L. and Zeldis , J. B.Primary hepatocellular carcinoma following nonspecific non‐B hepatitis with DNA negative for HBV DNA . Dig. Dis. Sci. , 32 , 1428 – 1430 ( 1987. ). [DOI] [PubMed] [Google Scholar]
  • 22. ) Yano , M. , Yatsuhashi , H. , Inoue , O. and Koga , M.Epidemiology of hepatitis C virus in Japan: role in chronic liver disease and hepatocellular carcinoma . J. Gastroenterol. Hepatol. (Suppl.) , 1 , 31 – 35 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 23. ) Tsukuma , H. , Fujimoto , I. , Oshima , A.and The Liver Cancer Study Group of Japan. Estimation of risk for hepatocellular carcinoma among HBsAg carriers and heavy drinkers in Japan . Acta Hepatol. Jpn. , 27 , 1281 – 1289 ( 1986. ). [Google Scholar]
  • 24. ) Alter , M. J. , Margolis , H. S. , Krawczynski , K. , Judson , F. N. , Mares , A. , Alexander , W. J. , Hu , P. Y. , Miller , J. K. , Gerber , M. A. , Sampliner , R. E. , Meeks , E. L. and Beach , M. J. , for The Sentinel Counties Chronic Non‐A, Non‐B Hepatitis Study Team . The natural history of community‐acquired hepatitis C in the United States . N. Engl. J. Med. , 327 , 1899 – 1905 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 25. ) Lau , J. Y. N. , Mizokami , M. , Ohno , T. , Diamond , D. A. , Kniffen , J. and Davis , G. L.Discrepancy between biochemical and virological responses to interferon‐α in chronic hepatitis C . Lancet , 342 , 1208 – 1209 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 26. ) Seeff , L. B. , Buskell‐Bales , Z. , Wright , E. C. , Durako , S. J. , Alter , H. J. , Iber , F. L. , Hollinger , F. B. , Gitnick , G. , Knodell , R. G. , Perrillo , R. P. , Stevens , C. E. , Hollingsworth , C. G.and The National Heart, Lung and Blood Institute Study Group. Long‐term mortality after transfusion‐associated non‐A, non‐B hepatitis . N. Engl. J. Med. , 327 , 1906 – 1911 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 27. ) Okamoto , H. , Kurai , K. , Okada , S. , Yamamoto , K. , Lizuka , H. , Tanaka , T. , Fukuda , S. , Tsuda , F. and Mishiro , S.Full‐lenght of a hepatitis C virus genome having poor homology to reported isolates: comparative study of four distinct genotypes . Virology , 188 , 331 – 341 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 28. ) Yu , M.‐W. and Chen , C.‐J.Elevated serum testosterone levels and risk of hepatocellular carcinoma . Cancer Res. , 53 , 790 – 794 ( 1993. ). [PubMed] [Google Scholar]
  • 29. ) Trichopoulos , D.Etiology of primary liver cancer and the role of steroidal hormones . Cancer Causes Control , 3 , 3 – 5 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 30. ) Stanford , J. L. , Thomas , D. B.and WHO Collaborative Study of Neoplasias and Steroid Contraceptives. Reproductive factors in the etiology of hepatocellular carcinoma . Cancer Causes Control , 3 , 37 – 42 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 31. ) Tzonou , A. , Zavitsanos , X. , Hsieh , C.‐C. and Trichopoulos , D.Liveborn children and risk of hepatocellular carcinoma . Cancer Causes Control , 3 , 171 – 174 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 32. ) La Vecchia , C. , Negri , E. , Franceschi , S. and D'Avanzo , B.Reproductive factors and the risk of hepatocellular carcinoma in women . Int. J. Cancer , 52 , 351 – 354 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 33. ) Henderson , B. E. , Preston‐Martin , S. , Edmondson , H. A. , Peters , R. L. and Pike , M. C.Hepatocellular carcinoma and oral contraceptives . Br. J. Cancer , 48 , 437 – 440 ( 1983. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. ) La Vecchia , C. , Negri , E. , Franceschi , S. and Parazzini , F.Oral contraceptives and primary liver cancer . Br. J. Cancer , 59 , 460 – 461 ( 1989. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. ) Hsing , W. A. , Hoover , R. N. , McLaughlin , J. K. , Co‐Chien , H. T. , Wacholder , S. , Blot , W. J. and Fraumeni , J. F. , Jr.Oral contraceptives and primary liver cancer among young women . Cancer Causes Control , 3 , 43 – 48 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 36. ) Tavani , A. , Negri , E. , Parazzini , F. , Franceschi , S. and La Vecchia , C.Female hormone utilization and risk of hepatocellular carcinoma . Br. J. Cancer , 67 , 635 – 637 ( 1993. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. ) Tsukuma , H. , Hiyama , T. , Oshima , A. , Sobue , T. , Fujimoto , I. , Kasugai , H. , Kojima , J. , Sasaki , Y. , Imaoka , S. , Horiuchi , N. and Okuda , S.A case‐control study of hepatocellular carcinoma in Osaka, Japan . Int. J. Cancer , 45 , 231 – 236 ( 1990. ). [DOI] [PubMed] [Google Scholar]
  • 38. ) Adami , H. O. , Hsing , A. W. , McLaughlin , J. K. , Trichopoulos , D. , Hacker , D. , Ekbom , A. and Persson , I.Alcoholism and liver cirrhosis in the etiology of primary liver cancer . Int. J. Cancer , 51 , 898 – 902 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 39. ) Trichopoulos , D. , MacMahon , B. , Spparos , L. and Merikas , G.Smoking and hepatitis‐B‐negative primary hepatocellular carcinoma . J. Natl. Cancer Inst. , 65 , 111 – 114 ( 1980. ). [PubMed] [Google Scholar]
  • 40. ) Lam , K.‐C. , Yu , M.‐C. , Leung , J. W. C. and Henderson , B. E.Hepatitis B virus and cigarette smoking; risk factors for hepatocellular carcinoma in Hong Kong . Cancer Res. , 42 , 5246 – 5248 ( 1982. ). [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES